Claris Lifesciences Limited


in
Claris Lifesciences Limited will invest INR 2,000 million for expansion, including biotechnology development. The company proposes to target the regulated markets of the US, UK, France, Germany andItaly. Among the semi-regulated markets, the company will focus on Brazil, China, Russia and Mexico.